Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Research Support, Non-U.S. Gov't"
topic_facet:"Antirheumatic Agents"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Research+Support%2C+Non-U.S.+Gov%27t%22&filter%5B%5D=topic_facet%3A%22Antirheumatic+Agents%22&lookfor=%221468-2060%22&type=ISN
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Research+Support%2C+Non-U.S.+Gov%27t%22&filter%5B%5D=topic_facet%3A%22Antirheumatic+Agents%22&lookfor=%221468-2060%22&type=ISN
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Research+Support%2C+Non-U.S.+Gov%27t%22&filter%5B%5D=topic_facet%3A%22Antirheumatic+Agents%22&lookfor=%221468-2060%22&type=ISN
PubPharm (1.161)
1
Anti-GM-CSF otilimab versus tofacitinib or placebo in patients with active rheumatoid arthritis and an inadequate response to conventional or biologic DMARDs : two phase 3 randomised trials (contRAst 1 and contRAst 2)
enthalten in:
Annals of the rheumatic diseases
| 2023
von
Fleischmann, R.
|
van der Heijde, D.
|
Strand, V.
| +19
Wird geladen...
2
Anti-GM-CSF otilimab versus sarilumab or placebo in patients with rheumatoid arthritis and inadequate response to targeted therapies : a phase III randomised trial (contRAst 3)
enthalten in:
Annals of the rheumatic diseases
| 2023
von
Taylor, P.
|
Weinblatt, M.
|
McInnes, I.
| +18
Wird geladen...
3
Effect of tapered versus stable treatment with tumour necrosis factor inhibitors on disease flares in patients with rheumatoid arthritis in remission : a randomised, open label, non-inferiority trial
enthalten in:
Annals of the rheumatic diseases
| 2023
von
Lillegraven, S.
|
Paulshus Sundlisæter, N.
|
Aga, A.
| +16
CommentIn: Ann Intern Med. 2023 Dec;176(12):JC139. - PMID 38048575
Wird geladen...
4
Bimekizumab treatment in biologic DMARD-naïve patients with active psoriatic arthritis : 52-week efficacy and safety results from the phase III, randomised, placebo-controlled, active reference BE OPTIMAL study
enthalten in:
Annals of the rheumatic diseases
| 2023
von
Ritchlin, C.
|
Coates, L.
|
McInnes, I.
| +12
Wird geladen...
5
Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis : 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial
enthalten in:
Annals of the rheumatic diseases
| 2023
von
Østergaard, M.
|
van Vollenhoven, R.
|
Rudin, A.
| +96
Wird geladen...
6
Three-month tapering and discontinuation of long- term, low-dose glucocorticoids in senior patients with rheumatoid arthritis is feasible and safe : placebo-controlled double blind tapering after the GLORIA trial
enthalten in:
Annals of the rheumatic diseases
| 2023
von
Almayali, A.
|
Boers, M.
|
Hartman, L.
| +16
Wird geladen...
7
Budget impact analysis and treatment availability with biosimilar TNF inhibitors in rheumatic diseases in Poland : real-world evidence using a nationwide database
enthalten in:
Annals of the rheumatic diseases
| 2023
von
Stajszczyk, M.
|
Obarska, I.
|
Jeka, S.
| +1
Wird geladen...
8
Safety profile of upadacitinib in patients at risk of cardiovascular disease : integrated post hoc analysis of the SELECT phase III rheumatoid arthritis clinical programme
enthalten in:
Annals of the rheumatic diseases
| 2023
von
Fleischmann, R.
|
Curtis, J.
|
Charles-Schoeman, C.
| +8
Wird geladen...
9
Irreversible covalent Bruton's tyrosine kinase inhibitor, TAS5315 versus placebo in rheumatoid arthritis patients with inadequate response to methotrexate : a randomised, double-blind, phase IIa trial
enthalten in:
Annals of the rheumatic diseases
| 2023
von
Takeuchi, T.
|
Tanaka, S.
|
Murata, M.
| +1
Wird geladen...
10
JAK inhibitors and the risk of malignancy : a meta-analysis across disease indications
enthalten in:
Annals of the rheumatic diseases
| 2023
von
Russell, M.
|
Stovin, C.
|
Alveyn, E.
| +10
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[117]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Research Support, Non-U.S. Gov't
Filter aufheben
Thema: Antirheumatic Agents
Medienart
1.161
Aufsätze
923
E-Artikel
923
E-Ressourcen
238
Gedruckte Aufsätze
Zeitschriftentitel
1.161
Annals of the rheumatic diseases
Thema
Antirheumatic Agents
Research Support, Non-U.S. Gov't
1.057
Journal Article
359
Randomized Controlled Trial
328
Methotrexate
323
YL5FZ2Y5U1
322
Tumor Necrosis Factor-alpha
318
Multicenter Study
255
Antibodies, Monoclonal
202
Antibodies, Monoclonal, Humanized
165
B72HH48FLU
165
Infliximab
146
Adalimumab
146
FYS6T7F842
139
Etanercept
138
OP401G7OJC
134
Comparative Study
131
Immunoglobulin G
127
Rheumatoid Arthritis
120
Receptors, Tumor Necrosis Factor
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
176
2020-
617
2010-2019
321
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
1.161
Englisch
Haven't found what you're looking for?
Wird geladen...